CoLucid Pharmaceuticals' (CLCD) Price Target Raised to $52 at Ladenburg Thalmann

September 6, 2016 9:10 AM EDT
Get Alerts CLCD Hot Sheet
Price: $36.00 -9.32%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade CLCD Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Ladenburg Thalmann maintained a Buy rating on CoLucid Pharmaceuticals (NASDAQ: CLCD) and raised its price target to $52.00 (from $23.00)

For an analyst ratings summary and ratings history on CoLucid Pharmaceuticals click here. For more ratings news on CoLucid Pharmaceuticals click here.

Shares of CoLucid Pharmaceuticals closed at $10.66 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Trader Talk

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment